Cargando…
Protein Corona Fingerprints of Liposomes: New Opportunities for Targeted Drug Delivery and Early Detection in Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) is the fourth cause of cancer-related mortality in the Western world and is envisaged to become the second cause by 2030. Although our knowledge about the molecular biology of PDAC is continuously increasing, this progress has not been translated into better p...
Autores principales: | Palchetti, Sara, Caputo, Damiano, Digiacomo, Luca, Capriotti, Anna Laura, Coppola, Roberto, Pozzi, Daniela, Caracciolo, Giulio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358751/ https://www.ncbi.nlm.nih.gov/pubmed/30650541 http://dx.doi.org/10.3390/pharmaceutics11010031 |
Ejemplares similares
-
Synergistic Analysis of Protein Corona and Haemoglobin Levels Detects Pancreatic Cancer
por: Caputo, Damiano, et al.
Publicado: (2020) -
Personalized Graphene Oxide-Protein Corona in the Human Plasma of Pancreatic Cancer Patients
por: Di Santo, Riccardo, et al.
Publicado: (2020) -
Interplay of protein corona and immune cells controls blood residency of liposomes
por: Giulimondi, Francesca, et al.
Publicado: (2019) -
Magnetic Levitation of Personalized Nanoparticle–Protein Corona as an Effective Tool for Cancer Detection
por: Quagliarini, Erica, et al.
Publicado: (2022) -
Stratifying Risk for Pancreatic Cancer by Multiplexed Blood Test
por: Digiacomo, Luca, et al.
Publicado: (2023)